Cell line · CVCL_0439
MNNG/HOS Cl #5
Cancer cell line, Homo sapiens. Osteosarcoma. 32 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. MNNG/HOS Cl #5. Cell lines, record CVCL_0439. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0439
On this page
Cell line
As Cellosaurus gives it.
- Name
- MNNG/HOS Cl #5
- Accession
- CVCL_0439
- RRID
- RRID:CVCL_0439
- Synonyms
MNNG/HOS, MNNG-HOS, MNNG HOS, HOS-MNNG, HOS/MNNG, MNNGHOS, MNNG-HOS (Cl#5), MNNG/HOS Clone F-5, MNNG, R-1059-D, TE85, Te85, TE-85, HOS-TE85, Hos TE-85, HOS TE 85, HOS TE85, HOS (TE85), HOS(TE85), HOS (TE85, Clone F5), MNNG-HOS (TE 85, clone F-5), TE-85 clone F-5, HOS-Te85, TE 85.T, TE 85 ClF-5, HOS-TE85 clone 5, TE-85 clone 5
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 13Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone, right femur (in situ)
- Parent
- HOS (CVCL_0312)
- Secondary accessions
- CVCL_3952
- Entry created
- 2012-04-04
- Entry updated
- 2025-11-27
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers32
2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MAT2A enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma. | Cell Rep Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells. | Cancers (Basel) | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells. | Front Oncol | 2022 | Its Methods give the RRID and name the line | PubMed | |
| METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. | EBioMedicine | 2022 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 32
See all 32 papersRelatives12
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | HOS | CVCL_0312 | Cell lines | |
| Derived from it | C1I | CVCL_2402 | Cell lines | |
| Derived from it | E111 | CVCL_2441 | Cell lines | |
| Derived from it | FNR-85-Cl 1 | CVCL_ZZ44 | Cell lines | |
| Derived from it | FNR-85-Cl 2 | CVCL_ZZ45 | Cell lines | |
| Derived from it | FNR-85-Cl 3 | CVCL_ZZ46 | Cell lines | |
| Derived from it | FNR-85-Cl 5 | CVCL_ZZ47 | Cell lines | |
| Derived from it | II b | CVCL_4347 | Cell lines | |
| Derived from it | KHOS/NP | CVCL_2546 | Cell lines | |
| Derived from it | KRIB | CVCL_AU05 | Cell lines |
1 to 10 of 12
See all 12 relativesCell banks7
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1547 | ATCC | |
| ATCC | CRL-7734 | Discontinued | Cellosaurus |
| ATCC | CRL-7735 | Discontinued | Cellosaurus |
| CLS | 300289 | CLS | |
| ECACC | 87070201 | ECACC | |
| KCB | KCB 2016037YJ | Cellosaurus | |
| KCLB | 21543 | KCLB |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0439
GET https://conductscience.org/api/cell-lines/v1/CVCL_0439/papers?page=2